Received May 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
2 additional individuals contracting the Hantavirus due to the adverse effect of the Pfizer vaccine named Pfizer-BioNTech; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HANTAVIRAL INFECTION (medically significant), outcome "unknown", described as "2 additional individuals contracting the Hantavirus due to the adverse effect of the Pfizer vaccine named Pfizer-BioNTech". Clinical course: An anonymous individual reported via phone call on 08May2026, the dead of a friend (Withheld) and 2 additional individuals contracting the Hantavirus due to the adverse effect of the Pfizer vaccine named Pfizer-BioNTech. The caller explained that the vaccines had no proper oversight and were not properly filtered. It is not clear from the report when the adverse events happened. The reporter mention that the most recent occurrence is "since 08Feb2021". No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202600048786 same reporter, drug, event; different patient;